Recurrent Bullous Pemphigoid: A Case Report. [PDF]
Gowda Venkatesha RR +4 more
europepmc +1 more source
Delayed-Onset Localized Bullous Pemphigoid on an Umbilical Hernia Repair Scar: An Example of Ruocco's Immunocompromised Cutaneous District. [PDF]
Tercan E +4 more
europepmc +1 more source
A Case of Nivolumab-Induced Bullous Pemphigoid-Successfully Treated with Rituximab. [PDF]
Amin R, Ranpura N, Hatic H.
europepmc +1 more source
Abrocitinib and dupilumab bridging therapy for bullous pemphigoid with insufficient response to initial corticosteroid therapy: a case report. [PDF]
Zhang H, Li L, Zhao S, Wu H, Zhu J.
europepmc +1 more source
Case Report: Dupilumab as a steroid-sparing therapeutic option in refractory anti-p200 pemphigoid: real-world effectiveness in a patient with significant comorbidities. [PDF]
Kyriakou A +10 more
europepmc +1 more source
A Clinical Study on Efficacy of Injection Cyclophosphamide Monthly Pulse in Patients with Autoimmune Bullous Disorders. [PDF]
Palanivel N +4 more
europepmc +1 more source
Venetoclax-associated bullous dermatitis: A BCL-2 inhibitor-linked autoimmune blistering disease. [PDF]
Delahaye T +3 more
europepmc +1 more source
Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers. [PDF]
Lyu X +5 more
europepmc +1 more source
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid in an Elderly Woman With Type 2 Diabetes Mellitus: A Case Report. [PDF]
Roa Alvarez G +4 more
europepmc +1 more source
FcεRII (CD23) in dermatological disorders: structure, function, and clinical implications. [PDF]
Zdanowska N +4 more
europepmc +1 more source

